Parker Herbert K sold $675K of TRS

Parker Herbert K sold 15,000 shares of TRIMAS CORP (TRS) at $45.03 ($0.68M total) on 2026-06-30 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Parker Herbert K
Published Jul 1, 2026, 8:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 1, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TRS
Neutral
medium confidence
Mentioned
$TRS
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRSNeutralLow
01

Why it matters

The disclosed sale amount ($675,465) is specific and new, but the 10b5-1 designation typically lowers the signal-to-noise for near-term trading decisions.

02

Market read

A director’s scheduled open-market sale under 10b5-1 is disclosed; likely limited impact beyond incremental sentiment.

03

What to watch

The sale is explicitly under a pre-arranged 10b5-1 plan, which often reflects scheduled liquidity rather than a new bearish thesis.

Relevance 4/10Novelty 4/10Timing: after-hours/filing time (SEC Form 4 filed 2026-07-01)

Background

The filing is an SEC Form 4 insider transaction for TRIMAS Corp, reported by a director.

Company-level read

Ticker impact

$TRSNeutralMedium confidence
Context

TRIMAS director Parker Herbert K sold 15,000 shares on 2026-06-30 at $45.0310 via a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

Form 4 provides a concrete transaction, but the presence of a pre-arranged 10b5-1 plan reduces interpretive signal versus discretionary selling.

Market effects

No sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still be interpreted as reduced confidence, especially if paired with other negative disclosures (not present here).

Key entities

  • TRIMAS CORP

    Issuer of the Form 4 insider transaction; director sold shares under a 10b5-1 plan.

  • Parker Herbert K

    Director who sold 15,000 shares on 2026-06-30 at $45.0310/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TRSMed

What TriMas (TRS) Said on Its Q3 Earnings Call

TriMas (TRS) reported Q3 earnings with Packaging operating profit up 11.9% to $20.4M, but Specialty Products saw profit decline. The company expects Packaging margins to reach 14% and full-year sales growth of 4-5%. Specialty Products faces production challenges, with margins expected to improve sequentially. TriMas reaffirmed its adjusted earnings outlook of $1.60-$1.70 per share and raised its sales growth outlook to 4-6%.

$TRSMedAI 8/10

TriMas (TRS) Q3 2026 Earnings Call Transcript

TriMas (TRS) reported Q3 2026 earnings with net sales up 7.7% to $178.7M, operating profit up 47.9% to $13.6M, and EPS up to $0.50. The company is executing cost reductions, leadership changes, and divesting Rapak. Year-to-date, sales rose 6.4% to $521.6M, operating profit up 35.8% to $41.2M, and EPS more than doubled to $1.25. The company repurchased 5.4M shares, reducing shares outstanding by 5%.

$TRSMed

TRIMAS REPORTS THIRD QUARTER 2026 RESULTS

TRIMAS CORP (TRS) filed an SEC Form 8-K — Results of Operations and Financial Condition. TRIMAS REPORTS THIRD QUARTER 2026 RESULTS • Third quarter net sales increased 7.7% year-over-year, driven by organic growth • Third quarter operating profit increased to $11.5 million, while adjusted operating profit increased 47.9% to $13.6 million • Third quarter diluted EPS in

$TRSMedAI 8/10

TriMas: Q3 Earnings Snapshot

TriMas Corp. (TRS) reported Q3 profit of $19.4M, or 53 cents per share, meeting Wall Street expectations. Revenue was $178.7M, exceeding forecasts. The company expects full-year earnings of $1.60-$1.70 per share.